Tokyo
Japan
6
2025-12-18
4
2022-05-10
These are the the leading inventors for applications assigned to SOLASIA PHARMA K.K.:
SOLASIA PHARMA K.K. based in Tokyo, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
SIRNA TARGETING RECQL1 HELICASE GENE
#2 | 2021-02-11 ✅ Patent 11,324,714 granted on 2022-05-10Organoarsenic compounds and methods for the treatment of cancer
#3 | 2021-02-11 ✅ Patent 11,324,713 granted on 2022-05-10Organoarsenic compounds and methods for the treatment of cancer
#4 | 2016-10-20COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
#5 | 2015-08-20 ✅ Patent 10,842,769 granted on 2020-11-24Organoarsenic compounds and methods for the treatment of cancer
#6 | 2013-06-06 ✅ Patent 8,865,764 granted on 2014-10-21Compounds and methods for the treatment of cancer
Also check out SOLASIA PHARMA K.K.'s (Tokyo, Japan) applicant profile with 4 patent applications submitted.
114522 ⎘